… used for prevention/treatment of osteoporosis, their side effects and … new therapeutic
modalities for osteoporosis. In the present study, all new therapeutic measures of osteoporosis have …

… to new therapies exemplified by the development of monoclonal antibodies for osteoporosis…
cells will lead to new small molecules made for osteoporosis treatment, perhaps causing …

… Osteoporosis is a common disease characterised by a systemic impairment of bone mass …
socioeconomic effect of osteoporosis, particularly postmenopausal osteoporosis, will increase …

… is the only available anabolic treatment of osteoporosis. A common feature of antiresorptive
as … The focus of this review is two new classes of anti-osteoporosis treatments; inhibition of …

… Several clinical trials were conducted in Japan to demonstrate that alfacalcidol maintains
BMD in both postmenopausal osteoporosis and senile osteoporosis. In 1992, Hayashi, et al …

… lasts only 1–2 min and allows the evaluation not only of the bone density changes during
a disease process but also after pharmacologic intervention for the treatment of osteoporosis. …

Approximately 70% to 80% of residents in nursing homes have osteoporosis. 1 e3 In this …
treating osteoporosis in nursing homes was demonstrated by the Vitamin D and Osteoporosis …

… two main issues in the field of osteoporosis management, particularly in the secondary …
osteoporosis, particularly regarding the effectiveness of anti-osteoporotic drugs in preventing new …

… conducting research in osteoporosis, with a focus on hormonal actions in bone. This review
summarizes new insights into the pathogenesis and treatment of osteoporosis and identifies …

… of care for treatment of postmenopausal osteoporosis and osteoporosis in men, oral … with
postmenopausal osteoporosis and also to yield a significantly decreased risk for new clinical …